525
Views
2
CrossRef citations to date
0
Altmetric
Brief Report

Altered SOCS3 DNA methylation within exon 2 is associated with increased mRNA expression in visceral adipose tissue in gestational diabetes

ORCID Icon, ORCID Icon, ORCID Icon, , , & ORCID Icon show all
Pages 488-494 | Received 21 Apr 2020, Accepted 24 Jul 2020, Published online: 12 Aug 2020

References

  • Chen C, Xu X, Yan Y. Estimated global overweight and obesity burden in pregnant women based on panel data model. PLoS One. 2018 Aug 9;13(8):e0202183.
  • Plagemann A. Maternal diabetes and perinatal programming. Early Hum Dev. 2011;87:7437.
  • Franzago M, Fraticelli F, Stuppia L, et al. Nutrigenetics, epigenetics and gestational diabetes: consequences in mother and child. Epigenetics. 2019 Mar;14(3):215–235.
  • Lain KY, Catalano PM. Metabolic changes in pregnancy. Clin Obstet Gynecol. 2007;50:938–948.
  • Ott R, Stupin JH, Melchior K, et al. Alterations of adiponectin gene expression and DNA methylation in adipose tissues and blood cells are associated with gestational diabetes and neonatal outcome. Clin Epigenetics. 2018 Oct 24;10(1):131.
  • Ott R, Melchior K, Stupin JH, et al. Reduced Insulin receptor expression and altered DNA methylation in fat tissues and blood of women with GDM and offspring. J Clin Endocrinol Metab. 2019 Jan 1;104(1):137–149.
  • Rancourt RC, Ott R, Schellong K, et al. Visceral adipose tissue alteration of PI3KR1 expression is associated with gestational diabetes but not promoter DNA methylation. Adipocyte. 2019 Dec;8(1):339–346.
  • Rancourt RC, Ott R, Ziska T, et al. Visceral adipose tissue inflammatory factors (TNF-Alpha, SOCS3) in gestational diabetes (GDM): epigenetics as a clue in GDM pathophysiology. Int J Mol Sci. 2020;21(2):479.
  • Boosani CS, Agrawal DK. Methylation and microRNA-mediated epigenetic regulation of SOCS3. Mol Biol Rep. 2015 Apr;42(4):853–872.
  • Ahima RS, Stanley TL, Khor VK, et al. Estrogen sulfotransferase is expressed in subcutaneous adipose tissue of obese humans in association with TNF-alpha and SOCS3. J Clin Endocrinol Metab. 2011 Jul;96(7):E1153–8.
  • Emanuelli B, Peraldi P, Filloux C, et al. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-alpha in the adipose tissue of obese mice. J Biol Chem. 2001 Dec 21;276(51):47944–47949.
  • Liu Z, Gan L, Zhou Z, et al. SOCS3 promotes inflammation and apoptosis via inhibiting JAK2/STAT3 signaling pathway in 3T3-L1 adipocyte. Immunobiology. 2015 Aug;220(8):947–953.
  • Xu K, Zhang X, Wang Z, et al. Epigenome-wide association analysis revealed that SOCS3 methylation influences the effect of cumulative stress on obesity. Biol Psychol. 2018 January;131:63–71.
  • Ali O, Cerjak D, Kent JW Jr, et al. Methylation array methylation of SOCS3 is inversely associated with metabolic syndrome in an epigenome-wide association study of obesity. Epigenetics. 2016;11(9):699–707.
  • Wahl S, Drong A, Lehne B, et al. Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity. Nature. 2017 Jan 5;541(7635):81–86.
  • Barberio MD, Nadler EP, Sevilla S, et al. Comparison of visceral adipose tissue DNA methylation and gene expression profiles in female adolescents with obesity. Diabetol Metab Syndr. 2019;11:98.
  • Karlseder J, Rotheneder H, Wintersberger E. Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol Cell Biol. 1996;16:1659–1667.
  • Huang YT, Chu S, Loucks EB, et al. Epigenome-wide profiling of DNA methylation in paired samples of adipose tissue and blood. Epigenetics. 2016;11(3):227–236.
  • Ott R, Stupin JH, Loui A, et al. Maternal overweight is not an independent risk factor for increased birth weight, leptin and insulin in newborns of gestational diabetic women: observations from the prospective ‘EaCH’ cohort study. BMC Pregnancy Childbirth. 2018 Jun 20;18(1):250.
  • Tsunoda T, Takagi T. Estimating transcription factor bindability on DNA. Bioinformatics. 1999;15(7/8):622–630.
  • Benjamini Y, Krieger AM, Yekutieli D. Adaptive linear step-up procedures that control the false discovery rate. Biometrika. 2006;93:491–507.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.